arrow
L

Luís Villela

universidad autonoma de sinaloa
H指数:14
被引数:644

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-world data on the clinical features, therapy patterns, and outcomes of older adults with diffuse large B-cell lymphoma in Latin America: A study from the Grupo de Estudio Latinoamericano de Linfoproliferativos (GELL)
2025-01-010
PRE
Central Nervous System Involvement in Aggressive ATLL: Can We Predict the Risk in a Devastating Complication? Epidemiology and Clinical Features from Latin America. a Collaborative Study from Grupo De Estudio Latino-Americano De Linfoproliferativo (GELL) &T-Cell Brazil Project (TCBP)

侵袭性ATLL的中枢神经系统受累:我们能否预测这一灾难性并发症的风险?流行病学和临床特征来自拉丁美洲。拉丁美洲淋巴增殖性疾病研究组(GELL)与巴西T细胞项目(TCBP)的协作研究。

BLOOD
IF23.1
2024-11-050
PRE
Real-world experience in older patients with diffuse large B-cell lymphoma treated in Latin America: A study by the Latin American study group of lymphoproliferative disorders (GELL)
2023-09-011
PRE
Treatment and Survival Outcomes of Waldenstrom Macroglobulinemia in Latin American Patients: A Multinational Retrospective Cohort Study
2022-08-019
OAAI
Real-World Data on Adult T-Cell Leukemia/Lymphoma in Latin America: A Study From the Grupo de Estudio Latinoamericano de Linfoproliferativos
2021-12-0118
OAAI
Analysis of IgG, IgA and IgM antibodies against SARS-CoV-2 spike protein S1 in convalescent and vaccinated patients with the Pfizer-BioNTech and CanSinoBio vaccines

辉瑞-BioNTech和CanSinoBio疫苗的恢复期和疫苗接种患者中针对SARS-CoV-2刺突蛋白S1的IgG,IgA和IgM抗体的分析

2021-10-2517
OA
Discriminant analysis and machine learning approach for evaluating and improving the performance of immunohistochemical algorithms for COO classification of DLBCL
2019-06-118
OAAI